Technology | November 24, 2014

Volpara Solutions to Showcase Volumetric Breast Imaging Tools at RSNA

The three quantitative breast imaging tools are built using Volpara Solutions software engine.

Volpara Solutions, VolparaAnalytics, VolparaDose, VolparaDensity, RSNA 2104

Photo courtesy of Volpara Solutions

Volpara Solutions will exhibit its complete suite of quantitative breast imaging tools built on the Volpara Solutions software engine that allows for personalized measurements of volumetric breast density, patient-specific dose, breast compression and other factors designed to maintain accuracy and consistent quality in breast screening. 

Cleared by the FDA, HealthCanada, the TGA and CE-marked, VolparaDensity is used by radiologists to objectively assess density from both digital mammography and tomosynthesis images to help doctors evaluate which women would benefit from additional screening.  Highly correlated to 3-D breast MR assessments, VolparaDensity is a reliable tool that automatically generates an objective measurement of volumetric breast density correlated to the ACR (American College of Radiology) breast density categories.  To date, nearly 4-million women have had their breast density analyzed using VolparaDensity. 

VolparaAnalytics assists in quality assurance by monitoring critical elements of the breast imaging process and generating key metrics to help breast imaging centers monitor the performance of technologists, readers, and mammography and tomosynthesis machines. VolparaAnalytics provides unique information such as average pressure applied by each technologist, and breast density profiles by mammography system, helping address potential issues early.

VolparaDose calculates mammography dose by using a standard mean glandular dose (MGD) algorithm along with patient-specific volumetric breast density to give a better estimate of the dose absorbed by the specific breast. The VolparaDose data can be inserted directly into patient letters on compatible mammography reporting systems, and sent to enterprise wide dose tracking systems. 

For information: visit www.volparasolutions.com

Related Content

LOCalizer Implantable Tag Cleared for Long-Term Breast Lesion Placement
Technology | Breast Imaging | January 21, 2019
Hologic announced that the U.S. Food and Drug Administration (FDA) has cleared the LOCalizer radiofrequency...
Novel Technique May Significantly Reduce Breast Biopsies
News | Breast Biopsy Systems | January 17, 2019
A novel technique that uses mammography to determine the biological tissue composition of a tumor could help reduce...
Digital Mammography Increases Breast Cancer Detection
News | Mammography | January 16, 2019
The shift from film to digital mammography increased the detection of breast cancer by 14 percent overall in the United...
Artificial Intelligence Used in Clinical Practice to Measure Breast Density
News | Artificial Intelligence | January 15, 2019
An artificial intelligence (AI) algorithm measures breast density at the level of an experienced mammographer,...
Sponsored Content | Videos | Breast Imaging | January 11, 2019
Supplemental screening with ABUS helps personalize breast care for women with dense breasts and offers advanced...
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Breast Cancer Patients Have Less Heart Damage With Heart Drug and Trastuzumab
News | Cardio-oncology | January 03, 2019
Breast cancer patients who take a heart drug at the same time as trastuzumab have less heart damage, according to a...
Opto-Acoustic Imaging Helps Differentiate Breast Cancer Molecular Subtypes
News | Ultrasound Women's Health | December 20, 2018
Seno Medical Instruments Inc. (Seno Medical) reported results of a study demonstrating that morphologic and functional...
Densitas Enters Platform Partnership With Blackford
News | Breast Density | December 19, 2018
Breast imaging analytics company Densitas Inc. announced the signing of a new Alliance Partner Agreement with Blackford...
Axillary Radiotherapy and Lymph Node Surgery Yield Comparable Outcomes for Breast Cancer
News | Radiation Therapy | December 18, 2018
Early-stage breast cancer patients with cancer detected in a sentinel lymph node biopsy had comparable 10-year...